Latest news with #45thAnnualGrowthStockConference
Business Wire
2 days ago
- Business
- Business Wire
Karman Space & Defense to Present at the William Blair 45th Annual Growth Stock Conference
HUNTINGTON BEACH, Calif.--(BUSINESS WIRE)-- Karman Space & Defense ('Karman', 'Karman Holdings, Inc.' or 'the Company') (NYSE: KRMN), a leader in the rapid design, development and production of critical, next-generation system solutions for launch vehicle, satellite, spacecraft, missile defense, hypersonic and UAS customers, today announced that its Chief Executive Officer, Tony Koblinski, and Chief Financial Officer, Mike Willis, will present at the William Blair 45 th Annual Growth Stock Conference on Thursday, June 5 at 11:20 a.m. Central Time. Conference Presentation Details: Time: 11:20 a.m. CT (12:20 p.m. ET) Webcast link: The audio portion of Karman's presentation will be broadcast live, and a replay will be available for six months at the link above, and on the investor relations section of the company's investor website at ABOUT KARMAN SPACE & DEFENSE We specialize in the rapid design, development, and production of next-generation technologies to combat near-peer nation state threats, focused on critical, integrated systems for the hypersonic, missile defense, UAV and space sectors. Our core technology offerings include propulsion, deployable shrouds, launchers, and energetic subsystems. Customers choose our advanced solutions to deliver mission success across a diverse set of existing and emerging programs supporting high-priority defense and commercial space sector initiatives. For more information, visit For additional media and information, please follow us LinkedIn X Instagram YouTube
Yahoo
2 days ago
- Business
- Yahoo
Veeva to Present at Upcoming Investor Conferences
PLEASANTON, Calif., May 30, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced participation in the following investor conferences: Baird 2025 Global Consumer, Technology & Services Conference, New York, NY. Paul Shawah, EVP Strategy, is presenting on Tuesday, June 3, 2025, at 10:50 a.m. Eastern Time. William Blair 45th Annual Growth Stock Conference, Chicago, IL. Brian Van Wagener, CFO, is presenting on Wednesday, June 4, 2025, at 1:20 p.m. Central Time. The above presentations will be webcast. Links to the live and archived webcast will be available on Veeva's investor relations website at About Veeva SystemsVeeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit Veeva uses its website as a means of disclosing material non-public information, announcing upcoming investor conferences, and for complying with its disclosure obligations under Regulation FD. Accordingly, you should monitor Veeva's investor relations website in addition to following its press releases, SEC filings, and public conference calls and webcasts. Investor Relations Contact: Gunnar HansenVeeva Systems Inc.267-460-5839ir@ Media Contact:Maria ScurryVeeva Systems Inc.781-366-7617pr@ View original content: SOURCE Veeva Systems
Business Insider
3 days ago
- Business
- Business Insider
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
ZUG, Switzerland and BOSTON, May 29, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team are scheduled to participate in the following investor conferences in June. William Blair's 45 th Annual Growth Stock Conference Date: Tuesday, June 3, 2025 Time: 11:20 a.m. CT Goldman Sachs' 46 th Annual Global Healthcare Conference Date: Monday, June 9, 2025 Time: 3:20 p.m. ET A live webcast will be available on the "Events & Presentations" page in the Investors section of the Company's website at A replay of the webcasts will be archived on the Company's website for 14 days following the presentation. About CRISPR Therapeutics Since its inception over a decade ago, CRISPR Therapeutics has evolved from a research-stage company advancing gene editing programs into a leader that celebrated the historic approval of the first-ever CRISPR-based therapy. The Company has a diverse portfolio of product candidates across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, cardiovascular, autoimmune, and rare diseases. In 2018, CRISPR Therapeutics advanced the first-ever CRISPR/Cas9 gene-edited therapy into the clinic to investigate the treatment of sickle cell disease and transfusion-dependent beta thalassemia. Beginning in late 2023, CASGEVY ® (exagamglogene autotemcel [exa-cel]) was approved in several countries to treat eligible patients with either of these conditions. The Nobel Prize-winning CRISPR technology has revolutionized biomedical research and represents a powerful, clinically validated approach with the potential to create a new class of potentially transformative medicines. To accelerate and expand its efforts, CRISPR Therapeutics has formed strategic partnerships with leading companies including Vertex Pharmaceuticals. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Boston, Massachusetts and San Francisco, California. To learn more, visit
Yahoo
3 days ago
- Business
- Yahoo
Tarsus to Participate in Upcoming Investor Conferences
IRVINE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to participate in the following upcoming investor conferences: William Blair 45th Annual Growth Stock Conference on Tuesday, June 3rd, at 6:00 a.m. PT / 8:00 a.m. CT Jefferies Global Healthcare Conference on Wednesday, June 4th, at 12:45 p.m. PT / 3:45 p.m. ET Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9th, at 10:20 a.m. PT / 1:20 p.m. ET Live webcasts and additional information can be accessed on the events section of the Tarsus website. Replays will be available on the Tarsus website within 48 hours and will be archived for a limited time. About Tarsus Pharmaceuticals, Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients, starting with eye care. Tarsus is advancing its pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care and infectious disease prevention. XDEMVY® (lotilaner ophthalmic solution) 0.25% is FDA approved in the United States for the treatment of Demodexblepharitis. Tarsus is also developing TP-04 for the potential treatment of Ocular Rosacea, and TP-05 as an oral tablet for the potential prevention of Lyme disease. Media Contact:Adrienne KempSr. Director, Corporate Communications(949) 922-0801AKemp@ Investor Contact:David NakasoneHead of Investor Relations(949) 620-3223DNakasone@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 days ago
- Business
- Yahoo
American Public Education Announces Upcoming Conference Participation
CHARLES TOWN, W.V., May 29, 2025 /PRNewswire/ -- American Public Education, Inc. (Nasdaq: APEI), a portfolio of education companies providing online and campus-based postsecondary education and career learning to over 125,000 students through four subsidiary institutions, today announced its upcoming investor conference participation schedule. William Blair's 45th Annual Growth Stock Conference – June 3-5, 2025 in Chicago, IL. Angela Selden, President and CEO will be present on June 5th at 8:00am CT and host 1x1 meetings. The presentation will be webcast and available at the Company's investor relations website at D.A. Davidson 1st Annual Technology + Consumer Conference – June 9-11, 2025 in Nashville, TN. Angela Selden, President and CEO and Rick Sunderland, CFO, will be available for 1x1 meetings with investors. About American Public Education American Public Education, Inc. (Nasdaq: APEI), through its institutions American Public University System, Rasmussen University, Hondros College of Nursing, and Graduate School USA, provides education that transforms lives, advances careers, and improves communities. APUS, which operates through American Military University and American Public University, is the leading educator to active-duty military and veteran students* and serves approximately 88,000 adult learners worldwide via accessible and affordable higher education. Rasmussen University is a 125-year-old nursing and health sciences-focused institution that serves approximately 14,600 students across its 20 campuses in six states and online. It also has schools of Business, Technology, Design, Early Childhood Education and Justice Studies. Hondros College of Nursing focuses on educating pre-licensure nursing students at eight campuses (six in Ohio, one in Indiana, and one in Michigan). It is the largest educator of PN (LPN) nurses in the state of Ohio** and serves approximately 3,700 total students. Graduate School USA is a leading training provider to the federal workforce with an extensive portfolio of government agency customers. It serves the federal workforce through customized contract training (B2G) to federal agencies and through open enrollment (B2C) to government professionals. Both APUS and Rasmussen University are institutionally accredited by the Higher Learning Commission (HLC), an institutional accreditation agency recognized by the U.S. Department of Education. Hondros is accredited by the Accrediting Bureau of Health Education Schools (ABHES). Graduate School USA is accredited by the Accrediting Council for Continuing Education & Training (ACCET). For additional information, visit *Based on FY 2019 Department of Defense tuition assistance data, as reported by Military Times, and Veterans Administration student enrollment data as of 2024. **Based on information compiled by the National Council of State Boards of Nursing and Ohio Board of Nursing. Company ContactFrank TutaloDirector, Public RelationsAmerican Public Education, 571-358-3042 Investor RelationsBrian M. Prenoveau, CFAMZ North AmericaDirect: 561-489-5315APEI@ View original content to download multimedia: SOURCE American Public Education, Inc.
